✦ LIBER ✦

842 EFFICACY AND TOLERABILITY OF PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN GENOTYPE 4 PATIENTS WITH CHRONIC HEPATITIS C (CHC) UNDER REAL LIFE CONDITIONS

✍ Scribed by E. Zehnter; S. Mauss; S. Kaiser; K. Boeker; T. Lutz; R. Heyne; C. John; G. Moog; A. Schober; R. Pfaff; A. Zipf; S. Racky; J. Lohmeyer; B. Bokemeyer; B. Kallinowski; T. Witthoeft; U. Alshuth; D. Hueppe

Book ID: 117376768
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60844-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

454 PREDICTIVE FACTORS OF THROMBOCYTOPEN

454 PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN

✍ S. Mauss; A. Schober; T. Lutz; G. Moog; M. Schuchmann; R. Heyne; C. John; W. Sch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 152 KB

782 CHRONIC HEPATITIS C GENOTYPE 4: EFFI

782 CHRONIC HEPATITIS C GENOTYPE 4: EFFICACY AND SAFETY OF THE TREATMENT WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN

✍ M. Diago; J. Boadas; R. Planas; R. Sola; J.A. del Olmo; J. Crespo; J.C. Erdozaín 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

404 DOSE REDUCTION OF PEGINTERFERON ALFA

404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS

✍ K. Boeker; S. Mauss; D. Hueppe; M. Schuchmann; W. Schiffelholz; A. Baumgarten; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Predictors of virologic relapse in patie

Predictors of virologic relapse in patients with chronic hepatitis C (CHC) treated with peginterferon alfa-2a (40KD) (pegasys) alone or in combination with ribavirin (copegus)

✍ V. Balan; S. Zeuzem; H. Sette; M. Fried; D. Jensen; G. Pastore; P. Marcellin; F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB